Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ENSG00000255959 locus encodes a long non-coding RNA (lncRNA) termed "Novel transcript, antisense to CCDC86" or CCDC86-AS1. By annotation, it is antisense to the protein-coding CCDC86 gene, but there is no evidence supporting a direct molecular or functional role for ENSG00000255959 in cell biology or disease. It is not considered a therapeutic target, nor is it a receptor, enzyme, transporter, or transcription factor. No drugs, biomarkers, or disease associations have been reported, and the entry appears primarily as a genomic annotation with limited biological characterization. When seeking targets for drug development, protein-coding genes such as CCDC86 (coiled-coil domain-containing protein 86) may be relevant, but ENSG00000255959 itself should not be considered a target. The canonical target abbreviation for therapeutic research is CCDC86 (not ENSG00000255959). ENSG00000255959 is best described as a "novel lncRNA, antisense to CCDC86" and lacks evidence for therapeutic targeting. The target as described (ENSG00000255959) is not a receptor, enzyme, transporter, or other actionable target, and thus is not a therapeutic target. There appear to be no misspellings, but its use as a target is incorrect for most drug discovery or receptor-focused research. The gene is indexed correctly in genomic databases, but does not fulfill criteria for a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CCDC86 (ENSG00000255959).